Antibe Therapeutics (ATBPF) Short Interest Ratio & Short Volume → Read this before you buy AI stocks (From InvestorPlace) (Ad) Free ATBPF Stock Alerts $0.22 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort Interest Antibe Therapeutics Short Interest DataCurrent Short Interest65,100 sharesPrevious Short Interest65,100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$14,035.56Short Interest Ratio0.0 Days to CoverLast Record DateApril 30, 2024Outstanding Shares53,010,000 sharesPercentage of Shares Shorted0.12%Today's Trading Volume0 sharesAverage Trading Volume27,352 sharesToday's Volume Vs. Average0% Short Selling Antibe Therapeutics ? Sign up to receive the latest short interest report for Antibe Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartATBPF Short Interest Over TimeATBPF Days to Cover Over TimeATBPF Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Antibe Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202465,100 shares $14,035.56 No ChangeN/A0 $0.22 4/15/202465,100 shares $14,035.56 +1,934.4%N/A0.7 $0.22 3/31/20243,200 shares $1,070.40 -64.0%N/A0.1 $0.33 3/15/20248,900 shares $2,891.61 -73.1%N/A0.1 $0.32 2/29/202433,100 shares $23,653.26 +234.3%N/A0.5 $0.71 2/15/20249,900 shares $6,811.20 No ChangeN/A0.6 $0.69 Get the Latest News and Ratings for ATBPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Antibe Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202410,400 shares $8,112.00 -9.6%N/A1.4 $0.78 12/31/202311,500 shares $7,843.00 +121.2%N/A0.7 $0.68 12/15/20235,200 shares $3,571.88 -17.5%N/A1.1 $0.69 11/30/20236,300 shares $3,433.50 -54.0%N/A0.8 $0.55 11/15/202313,700 shares $7,521.30 +17.1%N/A0.1 $0.55 10/31/202311,700 shares $5,382.00 -27.8%N/A0.2 $0.46 10/15/202316,200 shares $5,799.60 +211.5%N/A1.7 $0.36 9/30/20235,200 shares $1,863.06 -24.6%N/A0.2 $0.36 9/15/20236,900 shares $2,829.00 -76.4%N/A0.3 $0.41 8/31/202329,200 shares $11,554.44 -22.8%N/A1.1 $0.40 8/15/202337,800 shares $15,498.00 +563.2%N/A1.5 $0.41 7/31/20235,700 shares $2,053.14 -8.1%N/A0.4 $0.36 7/15/20236,200 shares $2,156.98 No ChangeN/A2.8 $0.35 6/30/20236,200 shares $2,170.00 -7.5%N/A2.6 $0.35 6/15/20236,700 shares $2,517.19 -71.7%N/A1.6 $0.38 5/31/202323,700 shares $8,752.41 +203.9%N/A1.3 $0.37 5/15/20237,800 shares $2,934.36 -27.8%N/A0.6 $0.38 4/30/202310,800 shares $4,342.68 -6.9%N/A3.1 $0.40 4/15/202311,600 shares $4,637.68 -78.6%N/A3.6 $0.40 3/31/202354,100 shares $23,766.13 -1.3%N/A2.5 $0.44 3/15/202354,800 shares $20,643.16 +260.5%N/A1.2 $0.38 2/28/202315,200 shares $5,668.08 -37.5%N/A1.7 $0.37 2/15/202324,300 shares $10,529.19 +22.7%N/A4.9 $0.43 1/31/202319,800 shares $8,401.14 +94.1%N/A0.8 $0.42 1/15/202310,200 shares $5,115.81 -56.8%N/A4.3 $0.50 12/30/202223,600 shares $7,622.80 -23.1%N/A2.5 $0.32 12/15/202230,700 shares $11,666.00 +44.8%N/A2.8 $0.38 11/30/202221,200 shares $7,420.00 +32.5%N/A3.2 $0.35 11/15/202216,000 shares $5,912.00 +3.9%N/A1.3 $0.37 10/31/202215,400 shares $5,998.30 +12.4%N/A3.1 $0.39 10/15/202213,700 shares $5,555.35 -8.7%N/A3 $0.41 9/30/202215,000 shares $6,718.50 -41.4%N/A1.1 $0.45 9/15/202225,600 shares $12,170.24 -13.8%N/A2.8 $0.48 8/31/202229,700 shares $14,362.92 -15.1%N/A2.3 $0.48He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs 8/15/202235,000 shares $17,570.00 -39.2%N/A3.3 $0.50 7/31/202257,600 shares $25,920.00 -26.9%N/A20.6 $0.45 7/15/202278,800 shares $37,248.76 +3.8%N/A17.1 $0.47 6/30/202275,900 shares $35,832.39 -5.8%N/A5.2 $0.47 6/15/202280,600 shares $38,833.08 +2.8%N/A6.3 $0.48 5/31/202278,400 shares $42,696.64 +5.0%N/A6.2 $0.54 5/15/202274,700 shares $39,591.00 +48.8%N/A6.2 $0.53 4/30/202250,200 shares $28,011.60 +8.9%N/A7 $0.56 4/15/202246,100 shares $27,293.51 +45.9%N/A3.7 $0.59 3/31/202231,600 shares $20,066.00 +3.3%N/A2.4 $0.64 3/15/202230,600 shares $17,448.12 -23.7%N/A1.6 $0.57 2/28/202240,100 shares $23,454.49 +74.4%N/A1.1 $0.58 2/15/202223,000 shares $12,811.00 +57.5%N/A1.5 $0.56 1/31/202214,600 shares $7,678.14 +630.0%N/A0.2 $0.53 1/15/20222,000 shares $1,115.80 -66.1%N/A0.1 $0.56 12/31/20215,900 shares $3,043.81 -65.7%N/A0.1 $0.52 12/15/202117,200 shares $8,536.36 -71.4%N/A0.4 $0.50 11/30/202160,100 shares $32,737.67 -41.1%N/A1.6 $0.54 11/15/2021102,000 shares $72,644.40 -42.3%N/A0.7 $0.71 10/29/2021176,800 shares $114,725.52 +665.4%N/A1.2 $0.65 10/15/202123,100 shares $18,225.90 +725.0%N/A0.4 $0.79 9/30/20212,800 shares $2,640.40 +180.0%N/A0 $0.94 9/15/20211,000 shares $948.40 +11.1%N/A0 $0.95 8/31/2021900 shares $900.00 -96.4%N/A0 $1.00 8/13/202124,700 shares $25,935.00 -88.2%N/A0.1 $1.05 7/30/2021208,400 shares $561,638.00 +10.7%N/A6.6 $2.70 7/15/2021188,200 shares $513,409.60 -0.1%N/A9.6 $2.73 6/30/2021188,300 shares $559,251.00 -3.7%N/A5.8 $2.97 6/15/2021195,500 shares $602,218.20 -8.2%N/A5.5 $3.08 5/28/2021212,900 shares $724,924.50 +8.0%N/A11 $3.41 5/14/2021197,200 shares $646,816.00 -5.6%N/A8.2 $3.28 4/30/2021208,900 shares $714,458.89 +6.8%N/A5.8 $3.42 4/15/2021195,600 shares $708,072.00 -12.6%N/A9.5 $3.62 3/31/2021223,700 shares $883,615.00 +41.5%N/A1.8 $3.95 3/15/2021158,100 shares $623,388.30 -54.4%N/A3.2 $3.94 2/26/2021346,600 shares $1.50 million +439.9%N/A2 $4.34 2/12/202164,200 shares $301,098.00 -17.3%N/A0.5 $4.69 1/29/202177,600 shares $219,297.60 +21.1%N/A1.8 $2.83 12/31/202028,600 shares $89,518.00 No ChangeN/A0.5 $3.13 11/30/202030,700 shares $9,513.93 +332.4%N/A0.1 $0.31 11/15/20207,100 shares $2,188.93 -64.5%N/A0.1 $0.31 10/30/202020,000 shares $4,800.00 No ChangeN/A0.2 $0.24 10/15/202020,000 shares $5,342.00 +52.7%N/A0.2 $0.27 9/30/202013,100 shares $3,445.30 No ChangeN/A0 $0.26 8/31/20201,300 shares $388.96 -93.1%N/A0 $0.30 8/14/202018,900 shares $5,934.60 -44.9%N/A0 $0.31 7/31/202034,300 shares $9,569.70 +2,350.0%N/A0.1 $0.28 7/15/20201,400 shares $408.52 -92.4%N/A0 $0.29 6/30/202018,300 shares $5,574.18 -36.2%N/A0 $0.30 6/15/202028,700 shares $10,705.10 +135.3%N/A0 $0.37He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs 5/29/202012,200 shares $3,782.00 +281.3%N/A0.1 $0.31 5/15/20203,200 shares $1,856.00 -98.3%N/A0 $0.58 4/30/2020191,600 shares $101,548.00 +787.0%N/A0.6 $0.53 4/15/202021,600 shares $10,584.00 -83.4%N/A0.1 $0.49 3/31/2020130,400 shares $70,416.00 -52.7%N/A0.3 $0.54 3/13/2020275,700 shares $137,850.00 +58.3%N/A0.6 $0.50 2/28/2020174,200 shares $64,454.00 +60.9%N/A0.8 $0.37 2/14/2020108,300 shares $49,818.00 -18.0%N/A0.2 $0.46 1/31/2020132,000 shares $62,040.00 +28.4%N/A0.4 $0.47 1/15/2020102,800 shares $49,344.00 -47.6%N/A0.3 $0.48 12/31/2019196,000 shares $76,440.00 -3.1%N/A1.4 $0.39 ATBPF Short Interest - Frequently Asked Questions What is Antibe Therapeutics' current short interest? Short interest is the volume of Antibe Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 65,100 shares of ATBPF short. Learn More on Antibe Therapeutics' current short interest. How does Antibe Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Antibe Therapeutics: Monopar Therapeutics Inc. (1.24%), Akari Therapeutics, Plc (0.03%), ABVC BioPharma, Inc. (7.35%), Elevai Labs, Inc. (0.44%), Avalo Therapeutics, Inc. (10.13%), MIRA Pharmaceuticals, Inc. (0.42%), Moleculin Biotech, Inc. (1.45%), Guardion Health Sciences, Inc. (14.33%), Imunon, Inc. (3.95%), Eterna Therapeutics Inc. (1.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Antibe Therapeutics stock? Short selling ATBPF is an investing strategy that aims to generate trading profit from Antibe Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Antibe Therapeutics? A short squeeze for Antibe Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATBPF, which in turn drives the price of the stock up even further. How often is Antibe Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATBPF, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Monopar Therapeutics Short Interest Data Akari Therapeutics Short Interest Data ABVC BioPharma Short Interest Data Elevai Labs Short Interest Data Avalo Therapeutics Short Interest Data MIRA Pharmaceuticals Short Interest Data Moleculin Biotech Short Interest Data Guardion Health Sciences Short Interest Data Imunon Short Interest Data Eterna Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ATBPF) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDoes this make you sick?Allegiance GoldThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts